These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1277220)

  • 1. Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
    Creaven PJ; Allen LM; Cohen MH; Nelson RL
    Cancer Treat Rep; 1976 Apr; 60(4):445-9. PubMed ID: 1277220
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of ifosfamide toxicity using dose fractionation.
    Rodriguez V; Bodey GP; Freireich EJ; McCredie KB; McKelvey EM; Tashima CK
    Cancer Res; 1976 Aug; 36(8):2945-8. PubMed ID: 1277203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.
    Morgan LR; Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Plotkin D; Tucker WG; Worrall PM
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):66-70. PubMed ID: 7163813
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
    Allen LM; Creaven PJ; Nelson RL
    Cancer Treat Rep; 1976 Apr; 60(4):451-8. PubMed ID: 1277221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
    Nelson RL; Creaven PJ; Cohen MH; Fossieck BE
    Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
    Slavik M; Saiers JH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):62-5. PubMed ID: 6836328
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the metabolism of isopnosphamide (NSC-109724) in man.
    Norpoth K
    Cancer Treat Rep; 1976 Apr; 60(4):437-43. PubMed ID: 1277219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies of ifosfamide for gynecological malignancies].
    Kohno I; Kazuta M; Miyao J; Kunimi N; Kawamoto M; Tanimura T; Fujiwara K; Sekiba K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1278-84. PubMed ID: 6870299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative pharmacology of cyclophosphamide and ifosfamide.
    Colvin M
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):2-7. PubMed ID: 6761865
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I clinical trial of isophosphamide (NSC-109724).
    Cohen MH; Creaven PJ; Tejada F; Hansen HH; Muggia F; Mittelman A; Selawry OS
    Cancer Chemother Rep; 1975; 59(4):751-5. PubMed ID: 1100226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isophosphamide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():237-47. PubMed ID: 6944261
    [No Abstract]   [Full Text] [Related]  

  • 13. Ifosfamide: should the honeymoon be over?
    Kamen BA; Frenkel E; Colvin OM
    J Clin Oncol; 1995 Feb; 13(2):307-9. PubMed ID: 7844590
    [No Abstract]   [Full Text] [Related]  

  • 14. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
    Bryant BM; Jarman M; Ford HT; Smith IE
    Lancet; 1980 Sep; 2(8196):657-9. PubMed ID: 6106781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies with ifosfamide in patients with malignant lymphoma.
    Rodriguez V; Cabanillas F; Bodey GP; Freireich EJ
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):87-92. PubMed ID: 7163815
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of ifosfamide and some metabolites in children.
    Kaijser GP; De Kraker J; Bult A; Underberg WJ; Beijnen JH
    Anticancer Res; 1998; 18(3B):1941-9. PubMed ID: 9677448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724).
    Houchens DP; Iorio A; Barzi A; Goldin A; Bonmassar E
    Cancer Chemother Rep; 1975; 59(5):967-73. PubMed ID: 1203899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF; Budd GT
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.